Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (6) Blankenstein, Thomas Prof. Dr. (180) Bunse, Mario Dr. (3) Cakmak-Görür, Nese Dr. (1) Clauß, Julian (1) Daniel, Peter Prof. Dr. (4) Dyck, Lydia Dr. (1) Filosa, Alessandro Dr. (1) Gerhardt, Holger Prof. Dr. (1) Henssen, Anton Prof. Dr. med. (1) Höpken, Uta Elisabeth PD Dr. (2) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Jeuthe, Sarah Dr. (1) Kammertöns, Thomas Dr. (38) Kopp, Joachim Dr. (5) Kühn, Ralf Dr. (1) Kunz, Severine Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (10) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Mertins, Philipp Dr. (3) Na, Il-Kang Dr. (2) Nguyen, Tam Hoai Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (18) Popp, Oliver Dr. (3) Rahn, Hans-Peter Dr. (1) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Rhein, Simone Dr. (2) Richter, Matthias (1) Rosenberger, Leonie Milena (1) Sawamiphak, Suphansa Dr. (1) Schlag, Peter M. Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Schütz, Anja Dr. (1) Siffrin, Volker (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (3) Uckert, Wolfgang Prof. Dr. (23) Walther, Wolfgang Prof. Dr. (7) Wolf, Susanne Dr. (2) (-) Willimsky, Gerald Dr. (35) 1997 (1) 1998 (1) 2000 (3) 2002 (1) 2005 (4) 2007 (1) 2008 (2) 2010 (4) 2011 (1) 2013 (5) 2017 (1) 2018 (3) 2019 (2) 2021 (1) 2022 (2) 2023 (2) 2024 (1) Advanced Light Microscopy (1) AG Müller/Dechend (ECRC) (3) Anchored Signalling (1) Animal Phenotyping (2) Bioinformatics and Omics Data Science (10) Cell Biology of Immunity (1) Chemical Biology (3) Computational methodologies and omic analytics (1) Computational Regulatory Genomics (5) Developmental Biology / Signal Transduction (7) Development and Function of Neural Circuits (1) Electron Microscopy (1) Epigenetic Regulation and Chromatin Architecture (2) Flow Cytometry (2) From Cell States to Function (4) Gastrointestinal Barrier, Regeneration and Carcinogenesis (1) Genetics and Genomics of Cardiovascular Diseases (5) Genome Diversification & Integrity (1) Genome Engineering & Disease Models (4) Genomics (5) Hypertension-caused End-Organ Damage (3) Hypertension-Mediated End-Organ Damage (3) Image Data Analysis (1) Immune Regulation and Cancer (2) Integrative Vascular Biology (1) Intracellular Proteolysis (1) Mathematical Cell Physiology (2) Mechanism-based Cancer Therapies (2) Microenvironmental Regulation in Autoimmunity and Cancer (3) Molecular and cellular basis of behavio (1) Molecular Biology of Peptide Hormones (5) Molecular Cardiovascular Research (3) (-) Molecular Immunology and Gene Therapy (35) Molecular Pathways in Cortical Development (2) Molecular Physiology of Somatic Sensation (6) Myology (3) Neuroimmunology Laboratory (1) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (3) Organoids (11) Pluripotent Stem Cells (3) Protein Production and Characterization (1) Proteome Dynamics (9) Proteomics (4) Proteomics and Metabolomics (8) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (6) Psychoneuroimmunology (1) Quantitative Developmental Biology (2) Quantitative Stem Cell Biology (2) RNA Biology and Posttranscriptional Regulation (20) Screening Unit (3) Systems Biology Imaging (8) Systems Biology of Gene Regulatory Elements (168) Transgenics (4) Translational Bioinformatics (6) Translational Cardiology and Functional Genomics (2) Translational Oncology of Solid Tumors (1) Translational Tumorimmunology (2) 35 Results: Active Filter: Willimsky, Gerald Dr.Molecular Immunology and Gene Therapy Sort: Result score Newest to oldest Oldest to newest March 14, 2023 / J Immunother Cancer Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse October 27, 2022 / J Immunother Cancer H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky February 16, 2023 / Front Immunol Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors L. Immisch G. Papafotiou N. Gallarín Delgado V. Scheuplein A. Paschen T. Blankenstein G. Willimsky September 12, 2024 / Haematologica A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma J. Krüger M. Obenaus I.W. Blau D. Hoser M. Vaegler H. Rauschenbach I. Anagnostopoulos K. Jöhrens V. Scheuplein E. Kieback J. Böhme A.C. Von Brünneck J. Krönke A. Busse G. Willimsky T. Blankenstein A. Pezzutto U. Keller A. Nogai Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4
March 14, 2023 / J Immunother Cancer Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky
April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse
October 27, 2022 / J Immunother Cancer H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky
February 16, 2023 / Front Immunol Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors L. Immisch G. Papafotiou N. Gallarín Delgado V. Scheuplein A. Paschen T. Blankenstein G. Willimsky
September 12, 2024 / Haematologica A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma J. Krüger M. Obenaus I.W. Blau D. Hoser M. Vaegler H. Rauschenbach I. Anagnostopoulos K. Jöhrens V. Scheuplein E. Kieback J. Böhme A.C. Von Brünneck J. Krönke A. Busse G. Willimsky T. Blankenstein A. Pezzutto U. Keller A. Nogai